Pro-Dex (PDEX) Competitors

AxoGen (NASDAQ:AXGN) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, community ranking, risk, earnings, profitability, media sentiment and valuation.

Which has better valuation and earnings, AXGN or PDEX?

Pro-Dex has lower revenue, but higher earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$194.52M	2.38	-$21.72M	-$0.15	-67.80
Pro-Dex	$64.12M	2.12	$2.13M	$2.80	14.91

Does the media refer more to AXGN or PDEX?

In the previous week, AxoGen had 4 more articles in the media than Pro-Dex. MarketBeat recorded 7 mentions for AxoGen and 3 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.63 beat AxoGen's score of -0.01 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pro-Dex	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer AXGN or PDEX?

AxoGen received 301 more outperform votes than Pro-Dex when rated by MarketBeat users. Likewise, 72.93% of users gave AxoGen an outperform vote while only 62.06% of users gave Pro-Dex an outperform vote.

Company	Underperform	Outperform
AxoGen	Outperform Votes 458 72.93%	Underperform Votes 170 27.07%
Pro-Dex	Outperform Votes 157 62.06%	Underperform Votes 96 37.94%

Do institutionals and insiders believe in AXGN or PDEX?

80.3% of AxoGen shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 2.8% of AxoGen shares are held by insiders. Comparatively, 47.5% of Pro-Dex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is AXGN or PDEX more profitable?

Pro-Dex has a net margin of 11.06% compared to AxoGen's net margin of -7.91%. Pro-Dex's return on equity of 21.68% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-7.91%	-14.91%	-7.49%
Pro-Dex	11.06%	21.68%	12.40%

Do analysts prefer AXGN or PDEX?

AxoGen presently has a consensus price target of $22.20, indicating a potential upside of 118.29%. Pro-Dex has a consensus price target of $56.00, indicating a potential upside of 34.10%. Given AxoGen's higher possible upside, research analysts clearly believe AxoGen is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Pro-Dex	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more volatility & risk, AXGN or PDEX?

AxoGen has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.17, indicating that its share price is 83% less volatile than the S&P 500.

Summary

AxoGen beats Pro-Dex on 9 of the 17 factors compared between the two stocks.